MLYS•benzinga•
Goldman Sachs Maintains Buy on Mineralys Therapeutics, Lowers Price Target to $24
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga